{
  "id": 12617000,
  "title": "Health Emergency Intelligence and Surveillance - Quarter three report 2026",
  "url": "https://urgent.news/2026/10/07/health-emergency-intelligence-and-surveillance-quarter-three-report",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-07T11:47:54.000Z",
  "source": {
    "name": "WHO Africa",
    "slug": "who-africa",
    "url": "https://www.afro.who.int/publications/health-emergency-intelligence-and-surveillance-quarter-three-report-2026"
  },
  "original_language": "en",
  "account": "The Health Emergency Intelligence and Surveillance - Quarter three report 2026 highlights the crucial role laboratory systems play in epidemic intelligence. In an impressive effort, over 50,000 GeneXpert cartridges were deployed for decentralized Mpox testing, extending beyond central reference laboratories. A total of 46 out of 47 Member States have now achieved genomic sequencing capacity.\n\nIn terms of quality assurance, 51 laboratories across 32 countries demonstrated a remarkable 89.4% detection success rate in the Mpox External Quality Assessment. This showcases the regional standardization of molecular testing. Surveillance efforts have reached every Member State, with 44 participating in the IDSR assessment. By week 52, weekly IDSR data completeness reached 94%, supported by 31 meningitis bulletins and dedicated outbreak analytics.\n\nThe report also emphasizes the speed and efficiency of detection processes. In 2025, 126 new signals were identified, with a median detection-to-verification time of only one day. Approximately 74% of outbreaks were detected within seven days of their occurrence. Innovations such as the expanded EIOS and speech-to-text radio mining have further enhanced this capability. Additionally, Weekly Bulletin readership has seen a fourfold growth.",
  "summary": "Health Emergency Intelligence and Surveillance - Quarter three report 2026 orlunwop@who.int Wed, 07/10/2026 - 12:47 Key messages Laboratory systems as the foundation of epidemic intelligence Deployment of more than 50 000 GeneXpert cartridges decentralized Mpox testing far beyond central reference laboratories, while 46 of 47 Member States now have genomic sequencing capacity. Quality assured,…",
  "key_points": [
    "Over 50,000 GeneXpert cartridges used for decentralized Mpox testing",
    "46 out of 47 Member States achieved genomic sequencing capacity",
    "89.4% detection success rate in Mpox External Quality Assessment"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}